Abstract: Embodiments of the present disclosure provide methods, systems, apparatuses, and computer program products for maintaining and updating a common message user interface (UI) shared among a plurality of group-based communication interfaces in a group-based communication system. The common message UI is rendered based on an updated version or a most up-to-date state of the common message UI when accessed by a client device associated with one of the plurality of group-based communication interfaces.

Abstract: The present application relates to novel imidazopyridinyl- or imidazopyrimidinyl-substituted, bridged 1,4-diazepane derivatives of formula (I), to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of respiratory disorders including, sleep-related respiratory disorders such as obstructive sleep apnoeas and central sleep apnoeas and snoring.

Abstract: The present disclosure describes a fuel system for an engine. The fuel system includes a fuel metering valve, a flow measuring system, and a controller in communication with the fuel metering valve and the flow measuring system. The fuel metering valve is operable to meter a flow rate of fuel based on a stroke of the fuel metering valve. The flow measuring system is configured to measure a mass flow rate of the fuel leaving the fuel system at a bandwidth greater than 20 Hz. The controller is configured to dynamically adjust the stroke of the fuel measuring system based on the mass flow rate of the fuel measured by the flow measuring system to change the flow rate of the fuel.

Abstract: The present invention relates to novel diazabicyclically substituted imidazo[1,2-a]pyrimidine derivatives, to methods for producing the same, to the use thereof either alone or in combinations for the treatment and/or prevention of diseases, as well as to their use for preparing medicaments for the treatment and/or prevention of diseases, especially for treatment and/or prevention of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnoea and snoring.

Abstract: The invention relates to new pharmaceutical dosage forms containing potent and selective TASK-1 and/or TASK-3 channel inhibitors, and the use of same to treat and/or prevent breathing disorders including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring.

Abstract: The invention relates to new pharmaceutical dosage forms containing potent and selective TASK-1 and/or TASK-3 channel inhibitors, and the use of same to treat and/or prevent breathing disorders including sleep-related breathing disorders such as obstructive and central sleep apnoea and snoring.

Abstract: Embodiments of the present disclosure provide methods, systems, apparatuses, and computer program products for maintaining and updating a common message user interface (UI) shared among a plurality of group-based communication interfaces in a group-based communication system. The common message UI is rendered based on an updated version or a most up-to-date state of the common message UI when accessed by a client device associated with one of the plurality of group-based communication interfaces.

Abstract: Systems and methods provide managing of communication between a remote data object hosted by a remote resource and a group-based communication interface of a group-based communication system.

Abstract: Embodiments of the present disclosure provide methods, systems, apparatuses, and computer program products for maintaining and updating a common message user interface (UI) shared among a plurality of group-based communication interfaces in a group-based communication system. The common message UI is rendered based on an updated version or a most up-to-date state of the common message UI when accessed by a client device associated with one of the plurality of group-based communication interfaces.

Abstract: Embodiments of the present disclosure provide methods, systems, apparatuses, and computer program products for building an rendering a message user interface (UI) within a group-based communication interface of a group-based communication system, where the message UI is rendered to a client device based on a customizable block configuration and on customizable block data that is received from an external application.

Abstract: The present invention relates generally to a process for producing glass products and to an apparatus suitable for the purpose. In the process, a melting apparatus is provided with a melting tank for producing a glass melt from glass raw materials and a top furnace. Part of the surface of the melting region of the melting apparatus is covered with the glass raw materials and at least a small portion of the surface of the melting region is uncovered. In addition, energy is introduced in such a way that a vertical temperature difference can be established, such that the temperature of the glass melt at the base is greater than the temperature of the atmosphere in the top furnace.

Abstract: A firearm includes a sighting device with a sight line and a first device which detects a movement of the firearm in a horizontal plane, and a second device which alters a course of the sight line depending on the movement detected by the first device.

Abstract: The present application relates to novel (2-phenylimidazo[1,2-a]pyridin-3-yl)methyl-substituted perhydropyrrolo[3,4-c]pyrrole derivatives, to methods for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of respiratory disorders including sleep-related respiratory disorders such as obstructive sleep apneas and central sleep apneas and snoring.

Abstract: A reference electrode insert (14) for an electrochemical test cell (10), in particular for testing lithium ion cells, comprising a reference electrode (46) and a sleeve (15) for holding the reference electrode (46), characterized in that the sleeve (15) and the annular reference electrode (46) form a structural unit, the reference electrode (46) being secured firmly and captively in the sleeve in an encapsulated manner.

Abstract: A test cell station (50) for at least one electrochemical test cell (10), comprising a housing (57), at least one receptacle (51) for the contacting insertion of at least one electrochemical test cell (10) and electrical connection means (54) for the electrical connection of a test cell (10) that has been inserted into the receptacle (51), characterized in that a thermally insulated temperature chamber (20) with a controllable cooling/heating device (27) for adjusting a temperature in the temperature chamber (20) is integrated into the test cell station (50), wherein the receptacle (51) is arranged in the test cell station (50) in such a way that the corresponding receptacle space for the electrochemical test cell (10) is arranged within the temperature chamber (20).

Abstract: Embodiments of the present disclosure provide methods, systems, apparatuses, and computer program products for maintaining and updating a common message user interface (UI) shared among a plurality of group-based communication interfaces in a group-based communication system. The common message UI is rendered based on an updated version or a most up-to-date state of the common message UI when accessed by a client device associated with one of the plurality of group-based communication interfaces.

Abstract: The present application relates to novel 3-phenylpropionic acid derivatives which carry a branched or cyclic alkyl substituent in the 3-position, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.

Abstract: The present invention relates to soluble guanylate cyclase (sGC) and to phosphodiesterases (PDEs) and the pharmacology of sGC stimulators, sGC activators and PDE inhibitors (PDE5i) in combination with a) treatments, leading to increased cGMP mobilization, and/or b) tretaments correcting and/or potentiatiating CFTR function, and/or c) treatments currently used as standard of care in Cystic Fibrosis, and/or d) antinflammatory treatments for the preparation of medicaments for the treatment of Cystic Fibrosis (CF) with improved efficacy over methods of treatments already known.

Abstract: The present application relates to novel 3-phenylpropionic acid derivatives which carry a branched or cyclic alkyl substituent in the 3-position, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.

Abstract: An online system communicates information describing deals guaranteeing impressions of content items within specified time periods to a content publisher at which the content items may be presented. The online system receives information describing an assignment of each deal to a placement position within a website for the content publisher. Upon receiving a request to present a content item to a viewing user of the online system at a placement position, the online system identifies candidate content items associated with deals assigned to the placement position, in which the candidate content items are associated with targeting criteria satisfied by the viewing user. Based at least in part on a number of impressions achieved by each candidate content item in relation to a number of impressions guaranteed for the candidate content item, the online system selects a candidate content item for presentation to the viewing user at the placement position.